THE 24th EDITION OF THE HABANO FESTIVAL KICKS OFF
- From
February 26th to March 1st ,Havana will once again become the world's epicenter of premium tobacco - The anniversary of Corporación Habanos, S.A. and the Quai D'Orsay and Trinidad brands will be the main protagonists of the 24th Habano Festival
The Festival will kick off with the opening of the
The Quai D'Orsay brand will be the star of the Mid-week Evening at the Cubanacán Protocol Lounge in El Laguito. During the event, attendees will participate in a tribute to the brand's 50th anniversary and will personally discover this "Special" vitola, in its world premiere presentation, in honor of this commemoration.
As a final touch to this edition of the Festival, the Gala Evening will take place in Hall C of the
A FULL PROGRAM OF ACTIVITIES
The traditional visits to plantations will take place in the zone of Vuelta Abajo*, in the Pinar del Río*, recognized worldwide as the best land to grow tobacco. In addition, attendees will have the opportunity to visit the Habanos factories of La Corona, Partagás,
The International Seminar will feature presentations such as "Two Cities United by Habanos," focusing on the Quai D'Orsay brand, and the panel "
The 24th Habano Festival, with an extensive agenda of activities, promises to be an unforgettable experience for those who wish to celebrate the rich history and culture of Habanos in
*(P.A.O.) Protected Appellations of Origin.
To consult the Humidor Auction catalogue click here.
Photo - https://mma.prnewswire.com/media/2344613/XXIII_Festival_del_Habano.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-24th-edition-of-the-habano-festival-kicks-off-302067839.html
SOURCE Habanos, S.A.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ALDI Invests in Even Lower Prices this Fall, Offering U.S. Shoppers $86 Million in Savings
- Jumio Announces Matt DeLauro as Chief Revenue Officer
- Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share